Serious adverse events and deaths in PCSK9 inhibitor trials reported on ClinicalTrials.gov: a systematic review
Expert Review of Clinical Pharmacology ; doi:10.1080/17512433.2020.1787832
The publisher has not yet granted permission to display this abstract.
Keywords: review / adverse events / PCSK9 inhibitors / all-cause mortality, ClinicalTrials.gov
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Expert Review of Clinical Pharmacology" .